Evidence map›Paper›PMID 41838984›Full record

ArticleCancer research communications2026

Characterization of Mitochondrial Double-Stranded RNA Levels in Non-Small Cell Lung Carcinoma.

Matthew R Krieger, Sandy Che-Eun S Lee, Ting Fu, Maya Cielo Cornejo, Kevin L He, Ryan Howe, Vanessa Saldivar, Angela L Zhang, Guillaume F Chanfreau, Michael A Teitell and 3 more

Abstract read
In one paragraph

Article in Cancer research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Matthew R Krieger *Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California.ORCID 0009-0003-9957-0969
Sandy Che-Eun S Lee *Pulmonary, Critical Care Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0002-7691-8104
Ting FuDepartment of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0003-0936-732X
Maya Cielo CornejoDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California.ORCID 0009-0005-9138-0751
Kevin L HeDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0001-5778-043X
Ryan HoweDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California.ORCID 0009-0004-3110-8257
Vanessa SaldivarMolecular Biology Institute, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0003-4020-5759
Angela L ZhangDepartment of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, California.ORCID 0009-0007-2214-7272
Guillaume F ChanfreauDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0002-2505-1950
Michael A TeitellJonsson Comprehensive Cancer Center, UCLA, Los Angeles, California.ORCID 0000-0002-4495-8750
Xinshu XiaoJonsson Comprehensive Cancer Center, UCLA, Los Angeles, California.ORCID 0000-0002-9362-8029
David B ShackelfordPulmonary, Critical Care Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0002-8270-898X
Carla M KoehlerDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0001-8685-2412

Funding

The Control of Gene Expression by Eukaryotic RibonucleasesR35GM130370 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Guillaume F Chanfreau · 2019 to 2026
$3.3M
Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationshipsR01CA262686 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Xinshu Grace Xiao · 2022 to 2026
$1.9M
Air Force Office of Scientific Research (AFOSR) FA9550-23-1-0737Graduate Education at UCLA (UCLA Graduate School)Jonsson Comprehensive Cancer Center, University of California, Los Angeles (JCCC) NIH/NCI P30CA016042Jonsson Comprehensive Cancer Center, University of California, Los Angeles (JCCC) NIH/NCI P50CA092131Jonsson Comprehensive Cancer Center, University of California, Los Angeles (JCCC) Postdoctoral FellowshipNational Cancer Institute (NCI) R01CA262686National Cancer Institute (NCI) R01 CA267721-01A1National Institute of General Medical Sciences (NIGMS) GM037981National Institute of General Medical Sciences (NIGMS) GM037981 and GM61721National Institute of General Medical Sciences (NIGMS) GM130370NCI NIH HHS R01 CA262686NIGMS NIH HHS R35 GM130370
6 · The paper itself

Abstract

Mitochondrial double-stranded RNA (mtdsRNA) is exported to the cytoplasm when mitochondrial RNA degradation is impaired, serving as a novel damage-associated molecular pattern for mitochondrial stress. Although mtdsRNA has been detected in certain cancers, its prevalence and functional role remain largely underexplored. Moreover, mtdsRNA is not readily detectable in large-scale computational datasets, reflecting technical limitations in the detection of structured mitochondrial transcripts. In this study, we used comprehensive computational characterization of non-small cell lung cancer (NSCLC) cell lines and identified elevated light-strand transcripts in a subset of cell lines, suggesting a potential for mtdsRNA formation. We stratify NSCLC lines into groups with high and low mtdsRNA abundance. Despite high cytoplasmic mtdsRNA levels in select NSCLC cell lines, we did not identify significant correlation with mtdsRNA abundance and type-I interferon (IFN-l) response. RT-qPCR analysis revealed that only USP18 transcripts amongst the IFN-l transcripts probed were significantly regulated in select NSCLC lines, indicating a partial or suppressed IFN-I response. Strand-specific RT-qPCR also revealed no bias in mitochondrial gene expression. These findings indicate that basal mtdsRNA accumulation alone is insufficient to trigger IFN-I signaling and may be tolerated in NSCLC, indicating adaptive mechanisms. Our findings suggest that mtdsRNAs could serve alternative nonimmunogenic roles in tumor biology. Importantly, our work reports that mtdsRNA is upregulated in a subset of NSCLC cell lines and in other cancer cell types, suggesting that mtdsRNA may serve as a new marker of mitochondrial dysfunction in cancer. SIGNIFICANCE: Our study identified and characterized NSCLC cell lines with elevated mtdsRNAs, suggesting that mtdsRNA may be a new signaling molecule in lung cancer for mitochondrial stress. We identified that accumulation of mtdsRNAs did not necessarily activate IFN-l response, indicating that NSCLC cell lines may have adaptive mechanisms to reduce IFN-l response.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMitochondriaRNA, Double-StrandedRNA, MitochondrialCell Line, TumorGene Expression Regulation, NeoplasticHumansRNA, Double-StrandedRNA, Mitochondrial

Identifiers

PMID41838984
PMCPMC13054796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.